NCT03668847View on ClinicalTrials.gov

DM-CHOC-PEN for Brain Tumors in AYA Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

August 31, 2021

Study Completion Date

September 30, 2021

Conditions
Advanced CancerBrain Metastases
Interventions
DRUG

DM-CHOC-PEN

DM-CHOC-PEN administration by IV infusion

Trial Locations (1)

70112

Tulane University Medical Center, New Orleans

All Listed Sponsors
lead

DEKK-TEC, Inc.

INDUSTRY

NCT03668847 - DM-CHOC-PEN for Brain Tumors in AYA Subjects | Biotech Hunter | Biotech Hunter